Fundraising FoxKoru Diagnostics
2 known investors
Find your way into Koru Diagnostics
Sign up to see every warm intro you have to Koru Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Koru Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Koru Diagnostics develops StaphGold, a milk screening ELISA test that detects subclinical Staphylococcus aureus mastitis in dairy herds using existing milk recording samples. It serves dairy farmers and vets to inform herd treatment decisions, improve milk quality and yield, and reduce mastitis spread.
Investors · 2
Frequently asked questions
- What does Koru Diagnostics do?
- Koru Diagnostics develops StaphGold, a milk screening ELISA test that detects subclinical Staphylococcus aureus mastitis in dairy herds using existing milk recording samples. It serves dairy farmers and vets to inform herd treatment decisions, improve milk quality and yield, and reduce mastitis spread.
- Who are Koru Diagnostics's investors?
- Koru Diagnostics's investors include Angel HQ, NZ Growth Capital Partners.